Thrombosis Research: Difference between revisions
No edit summary |
No edit summary |
||
| Line 32: | Line 32: | ||
with a goal of rapid dissemination of new information on thrombosis, hemostasis, and vascular biology to advance science and clinical care. The journal publishes peer-reviewed original research, along with reviews, editorials, and opinions and critics. Both basic and clinical studies are published. Publication of research which will lead to novel approaches in diagnosis, therapy, prognosis and prevention of thrombotic and hemorrhagic diseases is given high priority. |
with a goal of rapid dissemination of new information on thrombosis, hemostasis, and vascular biology to advance science and clinical care. The journal publishes peer-reviewed original research, along with reviews, editorials, and opinions and critics. Both basic and clinical studies are published. Publication of research which will lead to novel approaches in diagnosis, therapy, prognosis and prevention of thrombotic and hemorrhagic diseases is given high priority. |
||
Its impact factor as of 2021 is ''' |
Its impact factor as of 2021 is '''10.407''', has an average review time of 5.7 weeks and an average publication time of 0.7 weeks. The journal was established in 1972 by A.L. Copley. |
||
Associate Editors: |
Associate Editors: |
||
Revision as of 14:04, 17 August 2022
 |
| Discipline | Cardiology |
|---|---|
| Language | English |
| Edited by | Shannon Bates, Henri Versteeg |
| Publication details | |
| History | 1972–present |
| Publisher | |
| Frequency | Monthly |
| Hybrid | |
| Standard abbreviations | |
| ISO 4 | Thromb. Res. |
| Indexing | |
| CODEN | THBRAA |
| ISSN | 0049-3848 (print) 1879-2472 (web) |
| OCLC no. | 00985997 |
| Links | |
Thrombosis Research is an international peer-reviewed medical journal published by Elsevier with a goal of rapid dissemination of new information on thrombosis, hemostasis, and vascular biology to advance science and clinical care. The journal publishes peer-reviewed original research, along with reviews, editorials, and opinions and critics. Both basic and clinical studies are published. Publication of research which will lead to novel approaches in diagnosis, therapy, prognosis and prevention of thrombotic and hemorrhagic diseases is given high priority.
Its impact factor as of 2021 is 10.407, has an average review time of 5.7 weeks and an average publication time of 0.7 weeks. The journal was established in 1972 by A.L. Copley.
Associate Editors: S. Barco L. M. Baumann Kreuziger B. Bikdeli V. Bogdanov S. Gando A. Iorio F.A. Klok, M. Lordkipanidzé, C. G. Santos-Gallego H. Schulze E. Stavrou V Tagalakis R. Wu G. Young
Links
- https://www.journals.elsevier.com/thrombosis-research/most-cited-articles
- http://www.journals.elsevier.com/thrombosis-research/
- http://www.thrombosisresearch.com/
- https://twitter.com/thrombosisrese1
  | This article about a cardiology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |